A detailed history of Bluefin Capital Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 39,658 shares of LQDA stock, worth $422,357. This represents 0.03% of its overall portfolio holdings.

Number of Shares
39,658
Previous 23,100 71.68%
Holding current value
$422,357
Previous $277,000 42.96%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $147,366 - $233,633
16,558 Added 71.68%
39,658 $396,000
Q2 2024

Sep 10, 2024

BUY
$11.96 - $15.71 $276,276 - $362,901
23,100 New
23,100 $277,000
Q4 2023

Feb 16, 2024

BUY
$5.77 - $12.19 $144,250 - $304,750
25,000 New
25,000 $300,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.